Wang Y - Search Results

1

LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.

Zhang L, Wang L, Wang Y, Chen T, Liu R, Yang W, Liu Q, Tu K. Zhang L, et al. Among authors: wang l, wang y. Biomed Pharmacother. 2019 Jan;109:1140-1147. doi: 10.1016/j.biopha.2018.10.105. Epub 2018 Nov 6. Biomed Pharmacother. 2019. PMID: 30551364 Free article.

2

MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.

Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q, Yang W, Yao Y, Liu Q, Tu K. Dou C, et al. Among authors: wang y. Oncotarget. 2015 May 30;6(15):13216-28. doi: 10.18632/oncotarget.3916. Oncotarget. 2015. PMID: 25965836 Free PMC article.

3

High‑mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma.

Liu Z, Dou C, Wang Y, Jia Y, Li Q, Zheng X, Yao Y, Liu Q, Song T. Liu Z, et al. Among authors: wang y. Mol Med Rep. 2015 Oct;12(4):5997-6004. doi: 10.3892/mmr.2015.4182. Epub 2015 Aug 5. Mol Med Rep. 2015. PMID: 26252226

4

MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.

Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng X, Tu K. Yang W, et al. Among authors: wang y. Oncol Rep. 2015 Nov;34(5):2576-84. doi: 10.3892/or.2015.4210. Epub 2015 Aug 19. Oncol Rep. 2015. PMID: 26323375

5

BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma.

Yin G, Liu Z, Wang Y, Dou C, Li C, Yang W, Yao Y, Liu Q, Tu K. Yin G, et al. Among authors: wang y. BMC Cancer. 2016 Feb 15;16:103. doi: 10.1186/s12885-016-2154-z. BMC Cancer. 2016. Retraction in: BMC Cancer. 2023 Jun 13;23(1):542. doi: 10.1186/s12885-023-11051-6 PMID: 26879601 Free PMC article. Retracted.

6

PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.

Li Q, Liu Z, Xu M, Xue Y, Yao B, Dou C, Jia Y, Wang Y, Tu K, Zheng X, Yao Y. Li Q, et al. Among authors: wang y. Cancer Lett. 2016 May 28;375(1):190-198. doi: 10.1016/j.canlet.2016.02.053. Epub 2016 Mar 2. Cancer Lett. 2016. PMID: 26945969

7

Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.

Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y, Jia Y, Li Q, Zhang H, Tu K, Song T, Liu Q. Liu Z, et al. Among authors: wang y. Oncotarget. 2016 May 3;7(18):25350-65. doi: 10.18632/oncotarget.8129. Oncotarget. 2016. PMID: 26992218 Free PMC article.

8

Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma.

Wang Y, Liu Z, Yao B, Dou C, Xu M, Xue Y, Ding L, Jia Y, Zhang H, Li Q, Tu K, Jiao Y, Liu Q, Guo C. Wang Y, et al. Tumour Biol. 2016 Aug;37(8):11429-41. doi: 10.1007/s13277-016-4892-6. Epub 2016 Mar 22. Tumour Biol. 2016. PMID: 27002617 Free PMC article.

9

Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.

Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y, Jia Y, Li Q, Zhang H, Tu K, Song T, Liu Q. Liu Z, et al. Among authors: wang y. Oncotarget. 2016 Jun 14;7(24):36909-36923. doi: 10.18632/oncotarget.9377. Oncotarget. 2016. PMID: 27191994 Free PMC article.

10

Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma.

Xu M, Jia Y, Liu Z, Ding L, Tian R, Gu H, Wang Y, Zhang H, Tu K, Liu Q. Xu M, et al. Among authors: wang y. Onco Targets Ther. 2016 Jul 1;9:4023-35. doi: 10.2147/OTT.S107050. eCollection 2016. Onco Targets Ther. 2016. PMID: 27445493 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296,164 results

Search Page

Filters